[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$22sh sees increased engagement with discussions on investment potential and valuation concerns. A recent post from @3rdFloorCapital highlights a shift in investment strategy, impacting the asset's outlook.
This topic refers to the social media discussion and analysis of the financial asset $22sh.
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Month: XXXXXX +565%
1-Year High: XXXXX on 2025-06-26
1-Year Low: X on 2025-06-11
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X -XX%
1 Month: X +350%
1-Year High: X on 2025-07-21
1-Year Low: X on 2025-06-01
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $22sh in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
1 Week: X no change
1 Month: X +250%
1-Year High: X on 2025-07-21
1-Year Low: X on 2025-06-01
Top assets mentioned In the posts about $22sh in the last XX hours
Ziff Davis, Inc. Common Stock (ZD) Sarepta Therapeutics, Inc. (SRPT) Sarepta Therapeutics, Inc. (SRPT) BridgeBio Pharma, Inc. Common Stock (BBIO)
Top topics mentioned In the posts about $22sh in the last XX hours
100m, $zd, $srpt, sarepta therapeutics inc, stocks healthcare, $bbio, $335b, $29b, lev, $19b, investment
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"After the recent PR $SRPT has replaced $BBIO as my highest conviction long. Didn't take a single cent of profit on anything apart from ST options trades and actually tripled my equity position this morning. No matter how you slice it this business isn't worth $22/sh"
@3rdFloorCapital on X 2025-07-17 14:02:23 UTC XXX followers, 8491 engagements